Drug Action in the Central Nervous SystemPharmacodynamics--the mechanisms and pathways through which drugs influence living organisms--is the primary subject of Drug Action in the Central Nervous System. Many aspects of current working theories of epilepsy, depression, anxiety, schizophrenia, Parkinson's disease and other neurological and psychiatric disorders are based on studies of the pharmacodynamics of drug action in the central nervous system. The knowledge acquired from these studies can be successfully applied to the treatment of neurological and psychiatric disorders as well. The first three chapters of this book provide an overview of brain function and the basic principles of drug delivery and receptor function. Subsequent chapters analyze in full detail the pharmacodynamics of the centrally-acting drugs, including analgesics, anesthetics, muscle relaxers, migraine drugs, antiepileptics, antidepressants, antipsychotics, and sedative-hypnotics. Each of these chapters starts with a brief survey of the neurobiology of the systems affected by the drug class under discussion, followed by a detailed description of the mechanism of action, major side effects, and relevant pharmacokinetics of the drug class. The book also details the effects of street drugs on the nervous system. A chapter-by-chapter drug list is included in the appendix. Throughout the text, figures illustrate key concepts that do not yield readily to verbal description. Tables summarize DSM-IV criteria and list the therapeutic and side effects of the various drug classes. |
From inside the book
Results 1-3 of 27
Page 232
... antimuscarinic side effects nor likely to enhance DA activity in nontarget structures . Few pharmacokinetic studies have been done on the antimuscarinic drugs overall and benztropine in particular . Benztropine is assumed to have a ...
... antimuscarinic side effects nor likely to enhance DA activity in nontarget structures . Few pharmacokinetic studies have been done on the antimuscarinic drugs overall and benztropine in particular . Benztropine is assumed to have a ...
Page 265
... Antimuscarinic agents that are more ACh - specific such as trihexyphenidyl and orphenadrine are therefore better choices . Several antipsychotic drugs possess antimuscarinic actions as well as DA antagonist actions . These are the ...
... Antimuscarinic agents that are more ACh - specific such as trihexyphenidyl and orphenadrine are therefore better choices . Several antipsychotic drugs possess antimuscarinic actions as well as DA antagonist actions . These are the ...
Page 302
... antimuscarinic activity . TCAs that increase 5HT activity through reuptake inhibition and also have antimuscarinic actions ( e.g. , amitriptyline ) are most likely to produce this side effect . Also potentially related to their ...
... antimuscarinic activity . TCAs that increase 5HT activity through reuptake inhibition and also have antimuscarinic actions ( e.g. , amitriptyline ) are most likely to produce this side effect . Also potentially related to their ...
Contents
Introduction | 1 |
The Delivery of Drugs to the CNS | 19 |
Drugs and Receptors | 47 |
Copyright | |
9 other sections not shown
Other editions - View all
Common terms and phrases
ability accumbens acid action activity administered affinity agents agonists alcohol alpha alterations amine amphetamine amygdala analgesic anesthesia antagonists antidepressant antimuscarinic antipsychotic antipsychotic drugs associated barbiturates behavior benzodiazepines binding biotransformation blockade blood brain Ca2+ carbamazepine cells channels chronic clinical clozapine cocaine concentration cortex cortical decreased depolarization diazepam diffusion direct-acting disorder dopamine dosage dose drug class duce dystonia efficacy enzyme fibers function GABA half-life hallucinations hallucinogenic halothane headache hormone hypothesis increased induce inhibition inhibitors involved levodopa lithium mechanism membrane metabolism metabolites migraine morphine muscarinic muscle neurons neurotransmitter nicotinic normal NSAIDs occur opioid overdose pain pathway patients peripheral pharmacodynamic pharmacokinetic phenobarbital phenytoin plasma levels potency potential produce protein psychotic receptors reduce release respiratory depression responsible result reuptake second messengers sedation sedative-hypnotic seizure sensory serotonin side effects sleep solubility spinal striatum subunits symptoms synapse syndrome TCAs therapeutic therapy tion tolerance toxicity treatment tremor volatile anesthetics
References to this book
A Primer of Drug Action: A Concise Nontechnical Guide to the Actions, Uses ... Robert M. Julien No preview available - 2001 |
Der gitterlose Käfig: Wie unser Gehirn die Realität erschafft Manfred Schmidbauer No preview available - 2003 |